Reaction to severe stress, and adjustment disorders
|
disease |
|
Mental or Behavioral Dysfunction
|
1
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
response to antineoplastic agent
|
phenotype |
|
Organism Function
|
4
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Lymphoma, Mixed-Cell, Follicular
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphoma, Follicular, Grade 2
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphoma, Follicular, Grade 3
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphoma, Small Cleaved-Cell, Follicular
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphoma, Follicular, Grade 1
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Ph-Like Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
30
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Other alopecia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
Alopecia, Androgenetic, 3
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
Alopecia, Androgenetic, 2
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
Alopecia, Androgenetic, 1
|
disease |
|
Disease or Syndrome
|
39
|
104
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Hypotension, Orthostatic
|
phenotype |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
82
|
21
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Alopecia, Male Pattern
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
91
|
743
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
Congenital hypoplasia of kidney
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
96
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Androgenetic Alopecia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
112
|
107
|
0.100 |
None |
1.000 |
2 |
2
|
2016 |
2017 |
SVEINSSON CHORIORETINAL ATROPHY
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
139
|
30
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Plasmacytoma
|
disease |
Neoplasms; Immune System Diseases
|
Neoplastic Process
|
142
|
8
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |
Neoplastic Cell Transformation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
143
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lymphoma, Large-Cell, Follicular
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
153
|
6
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Primary central nervous system lymphoma
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
156
|
4
|
0.010 |
None |
< 0.001 |
1 |
|
2014 |
2014 |
Iron deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
179
|
13
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Varicosity
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
188
|
51
|
0.100 |
None |
1.000 |
2 |
1
|
2018 |
2019 |
Anorexia Nervosa
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
202
|
72
|
0.110 |
None |
1.000 |
1 |
1
|
2017 |
2017 |